Lixiang Jiang

Title: Innovations in Alzheimer's Treatment by Lixiang Jiang

Introduction

Lixiang Jiang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of Alzheimer's disease research through his innovative approaches and patented methods. His work focuses on the application of specific proteins and genetic methods to combat the challenges posed by this debilitating condition.

Latest Patents

Lixiang Jiang holds a patent titled "Application of PI4KIIIA protein and related membrane protein complex in treating Alzheimer's disease." This patent outlines a genetic method to down-regulate RBO/EFR3/EFR3A/EFR3B proteins, TTC7 protein, or PI4KIIIα enzyme protein. These proteins interact with each other to reduce the accumulation of Aβ within neurons, thereby addressing age-dependent synaptic transmission failure. The patent also describes methods for using inhibitors to treat Alzheimer's disease and for screening drugs that promote Aβ secretion by nerve cells.

Career Highlights

Lixiang Jiang is associated with Jiangsu Nuo-Beta Pharmaceutical Technology Co. Ltd., where he continues to advance his research. His innovative work has the potential to improve the learning and memory abilities of Alzheimer's model mice, showcasing the practical applications of his research.

Collaborations

Lixiang Jiang collaborates with notable colleagues, including Xiao Xun Zhang and Le Zhang, who contribute to his research efforts. Their combined expertise enhances the potential for breakthroughs in Alzheimer's treatment.

Conclusion

Lixiang Jiang's innovative approaches to treating Alzheimer's disease through his patented methods represent a significant advancement in medical research. His work not only addresses critical challenges in the field but also opens new avenues for potential therapies.